Kamran Imam
Allergy & Immunology · Riverside, CANPI 1013495431
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.9%), food and beverage and grants — rather than concentrated in one kind of arrangement. GSK accounts for 61.3% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $12,147 and has fallen 78.3% since, to $2,630 in 2025.
Across 188 payments — averaging $95.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$11K
- AstraZeneca$1K
- Regeneron$1K
- Regeneron Healthcare Solutions, Inc.$594
- Sanofi$555
- CSL Behring$466
- plus $3K from 21 others
What the payments were for
- Speaking & faculty fees$9,99956%
- Grants$1,0006%
- Food & beverage$6,75538%
- Education$1221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 29 | $10,966 |
| AstraZeneca | 21 | $1,310 |
| Regeneron | 1 | $1,000 |
| Regeneron Healthcare Solutions, Inc. | 12 | $594 |
| Sanofi | 22 | $555 |
| CSL Behring | 16 | $466 |
| Pharming Healthcare, Inc. | 12 | $461 |
| Genentech USA, Inc. | 11 | $424 |
| Biocryst US Sales Co., LLC | 12 | $421 |
| Novartis | 9 | $260 |
| Grifols USA, LLC | 7 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $223 |
| Amgen(2 entities) | 4 | $168 |
| Genentech, Inc. | 2 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Dermavant Sciences, Inc. | 1 | $90 |
| Teva Pharmaceuticals USA, Inc. | 1 | $77 |
| Ionis Pharmaceuticals, Inc. | 2 | $76 |
| Alk-abello, Inc | 3 | $71 |
| Kaleo, Inc. | 3 | $53 |
| Boehringer Ingelheim | 3 | $50 |
| Blueprint Medicines Corporation | 2 | $48 |
| Incyte Corporation | 2 | $33 |
| Mylan Specialty L.p. | 1 | $24 |
| AbbVie | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,875 in reported general payments places this provider in the 85th percentile of 426 allergy & immunology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 16 | $300 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Riverside
- Raffi TachdjianSanta Monica$3.7M
- Bob GengSan Diego$3.3M
- Vinay MehtaLaguna Niguel$1.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Brian Modenala Jolla$453K
- Heena Shah PatelUpland$428K
- Jacob OffenbergerGranada Hills$419K
- Myron LiebhaberSanta Barbara$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.